Yki-Järvinen H - Search Results

1

Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.

Luukkonen PK, Zhou Y, Sädevirta S, Leivonen M, Arola J, Orešič M, Hyötyläinen T, Yki-Järvinen H. Luukkonen PK, et al. J Hepatol. 2016 May;64(5):1167-1175. doi: 10.1016/j.jhep.2016.01.002. Epub 2016 Jan 11. J Hepatol. 2016. PMID: 26780287

2

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H. Seppälä-Lindroos A, et al. J Clin Endocrinol Metab. 2002 Jul;87(7):3023-8. doi: 10.1210/jcem.87.7.8638. J Clin Endocrinol Metab. 2002. PMID: 12107194

3

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.

Tiikkainen M, Häkkinen AM, Korsheninnikova E, Nyman T, Mäkimattila S, Yki-Järvinen H. Tiikkainen M, et al. Diabetes. 2004 Aug;53(8):2169-76. doi: 10.2337/diabetes.53.8.2169. Diabetes. 2004. PMID: 15277403 Clinical Trial.

4

The fatty liver and insulin resistance.

Yki-Järvinen H, Westerbacka J. Yki-Järvinen H, et al. Curr Mol Med. 2005 May;5(3):287-95. doi: 10.2174/1566524053766031. Curr Mol Med. 2005. PMID: 15892648 Review.

5

Fat in the liver and insulin resistance.

Yki-Järvinen H. Yki-Järvinen H. Ann Med. 2005;37(5):347-56. doi: 10.1080/07853890510037383. Ann Med. 2005. PMID: 16179270 Free article. Review.

6

Arterial stiffness and insulin resistance.

Westerbacka J, Yki-Järvinen H. Westerbacka J, et al. Semin Vasc Med. 2002 May;2(2):157-64. doi: 10.1055/s-2002-32039. Semin Vasc Med. 2002. PMID: 16222607 Review.

7

Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes.

Juurinen L, Tiikkainen M, Häkkinen AM, Hakkarainen A, Yki-Järvinen H. Juurinen L, et al. Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E829-35. doi: 10.1152/ajpendo.00133.2006. Epub 2006 Nov 7. Am J Physiol Endocrinol Metab. 2007. PMID: 17090752 Free article. Clinical Trial.

8

Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.

Pietiläinen KH, Sysi-Aho M, Rissanen A, Seppänen-Laakso T, Yki-Järvinen H, Kaprio J, Oresic M. Pietiläinen KH, et al. PLoS One. 2007 Feb 14;2(2):e218. doi: 10.1371/journal.pone.0000218. PLoS One. 2007. PMID: 17299598 Free PMC article.

9

Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.

Kolak M, Westerbacka J, Velagapudi VR, Wågsäter D, Yetukuri L, Makkonen J, Rissanen A, Häkkinen AM, Lindell M, Bergholm R, Hamsten A, Eriksson P, Fisher RM, Oresic M, Yki-Järvinen H. Kolak M, et al. Diabetes. 2007 Aug;56(8):1960-8. doi: 10.2337/db07-0111. Epub 2007 Jul 9. Diabetes. 2007. PMID: 17620421

10

Fatty liver: a novel component of the metabolic syndrome.

Kotronen A, Yki-Järvinen H. Kotronen A, et al. Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38. doi: 10.1161/ATVBAHA.107.147538. Epub 2007 Aug 9. Arterioscler Thromb Vasc Biol. 2008. PMID: 17690317 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters